Martin Edwards

Martin Edwards is an accomplished board member and senior advisor with extensive experience in the pharmaceutical and biotechnology industries. Presently serving as a Board Member at SiteOne Therapeutics, Inc., and Verona Pharma, as well as a Senior Advisor at Pivotal bioVenture Partners, Martin's past roles include Board Memberships at Inozyme Pharma, Reata Pharmaceuticals, Inc., and Morphic Holdings Inc. Martin spent 17 years as a Senior Partner at Novo Holdings and held the position of Adjunct Professor at Copenhagen Business School. Academically, Martin holds a Bachelor of Science and M.B. ChB from Manchester Medical School, an MBA from the University of Warwick, and postgraduate qualifications in internal medicine, general practice, and pharmaceutical medicine.